5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.91▲ | 4.85▲ | 4.85▲ | 4.86▲ | 4.77▲ |
MA10 | 4.88▲ | 4.81▲ | 4.80▲ | 4.96▼ | 4.50▲ |
MA20 | 4.85▲ | 4.78▲ | 4.74▲ | 4.68▲ | 4.88▲ |
MA50 | 4.80▲ | 4.81▲ | 4.97▼ | 4.44▲ | 8.85▼ |
MA100 | 4.73▲ | 4.98▼ | 4.89▲ | 4.95▼ | 9.37▼ |
MA200 | 4.84▲ | 4.83▲ | 4.47▲ | 8.39▼ | 10.76▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.008▲ | 0.023▲ | 0.036▲ | 0.002▲ | 0.313▲ |
RSI | 68.033▲ | 62.791▲ | 56.923▲ | 56.707▲ | 40.963▼ |
STOCH | 94.550▲ | 86.662▲ | 89.983▲ | 42.210 | 58.202 |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -47.321 | -27.604 |
CCI | 101.775▲ | 199.236▲ | 128.641▲ | -17.388 | 60.534 |
MA | $YMAB Price Crossed Above MA(13) | Set Alert |
Wednesday, June 11, 2025 06:22 AM
So should Y-mAbs Therapeutics (NASDAQ:YMAB) shareholders be worried about its cash burn? For the purposes of this article, cash burn is the annual rate at which an unprofitable co ...
|
Wednesday, May 28, 2025 05:00 PM
The latest analyst rating for Y-mAbs Therapeutics (NASDAQ:YMAB) was provided by Oppenheimer, and Y-mAbs Therapeutics maintained their outperform rating. Analysts arrive at stock ratings after ...
|
Monday, May 26, 2025 08:02 PM
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) has presented the early-stage clinical data from its GD2-SADA PRIT trial at the Advances in Neuroblastoma Research (ANR) Meeting in Washington, D.C.The ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 4.74 | 4.94 | 4.62 | 4.94 | 97,216 |
13/06/25 | 4.63 | 4.88 | 4.46 | 4.71 | 470,855 |
12/06/25 | 4.90 | 4.915 | 4.59 | 4.63 | 160,497 |
11/06/25 | 5.17 | 5.19 | 4.9118 | 4.93 | 153,696 |
10/06/25 | 5.16 | 5.23 | 5.04 | 5.095 | 90,392 |
09/06/25 | 5.36 | 5.47 | 5.03 | 5.08 | 153,236 |
06/06/25 | 5.18 | 5.41 | 5.14 | 5.27 | 109,600 |
05/06/25 | 4.97 | 5.12 | 4.75 | 5.10 | 142,083 |
04/06/25 | 4.88 | 5.155 | 4.88 | 4.96 | 192,317 |
03/06/25 | 4.78 | 4.96 | 4.685 | 4.87 | 119,297 |
|
|
||||
|
|
||||
|
|